Promise Proteomics SAS

https://www.promise-proteomics.com

PX'Therapeutics is a biopharmaceutical contract research and manufacturing organisation specialising in the development of therapeutic antibodies and recombinant proteins from early research stage up to clinical grade GMP manufacturing. With more than 160 clients in Europe, North America and Japan, PX'Therapeutics has acquired an extensive knowledge in the production of valuable therapeutic candidates. *

	Start	2019-07-01 renamed
	Group	Aguettant (Group)
	Predecessor	PX’Therapeutics S.A.
	Industry	contract manufacturing (biologicals)
	Person	Rougemond, Eric (Aguettant 201302– CEO)
	Person 2	Rousselle, Tristan (Protein’eXpert 200011–201306 CEO + Co-Founder LEFT 6/13 before Genome Express)

	Region	Grenoble
	Country	France
	Street	7 parvis Louis Néel BHT 52 A, CS 20050
	City	38040 Grenoble cedex 9
	Tel	+33-4-3802-3650
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2012-10-01)
	Currency	EUR
	Annual sales	8,500,000 (revenues (2011) 2011-12-31)

		* Document for »About Section«:

		Record changed: 2025-03-16

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x200px

More documents for Aguettant (Group)

[1] PX’Therapeutics S.A.. (2/20/19). "Press Release: 2019 – PX’Therapeutics Develops Its Services Offer"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com